Ozone exposure in the culture medium inhibits enterovirus 71 virus replication and modulates cytokine production in rhabdomyosarcoma cells

Antiviral Research

Volumn 76, Issue 3, 2007, Pages 241-251

  Lin, Ya Ching ^a   Juan, Hao Chan ^a   Cheng, Yi Chen ^a  

^a FOOYIN UNIVERSITY   (Taiwan)

Author keywords

Cytokine production; Enterovirus 71; Inhibition of virus replication; Ozone

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; OZONE; TUMOR NECROSIS FACTOR ALPHA;

AIR; ANTIVIRAL ACTIVITY; ARTICLE; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EXPOSURE; DRUG INHIBITION; ENTEROVIRUS 71; MODULATION; NONHUMAN; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SARCOMA CELL; SURVIVAL TIME; VIRUS INFECTION; VIRUS REPLICATION;

CELL LINE, TUMOR; CELL SURVIVAL; CULTURE MEDIA; CYTOKINES; ENTEROVIRUS A, HUMAN; HUMANS; NITRIC OXIDE; OZONE; VIRUS REPLICATION;

HUMAN ENTEROVIRUS 71;

EID: 35349002713     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.07.004     Document Type: Article

References (77)

1. AbuBakar S., Chee H.Y., Al-Kobaisi M.F., Xiaoshan J., Chua K.B., and Lam S.K. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 61 (1999) 1-9
2. Akaike T., and Maeda H. Nitric oxide and virus infection. Immunology 101 (2000) 300-308
3. Akaike T., Fujii S., Kato A., Yoshitake J., Miyamoto Y., Sawa T., Okamoto S., Suga M., Asakawa M., Nagai Y., and Maeda H. Viral mutation accelerated by nitric oxide production during infection in vivo. FASEB J. 14 (2000) 1447-1454
4. Akey D.H., and Walton T.E. Liquid-phase study of ozone inactivation of Venezuelan equine encephalomyelitis virus. Appl. Environ. Microbiol. 50 (1985) 882-886
5. Arsalane K., Gosset P., Vanhee D., Voisin C., Hamid Q., Tonnel A.B., and Wallaert B. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am. J. Respir. Cell. Mol. Biol. 13 (1995) 60-68
6. Arimoto M., Sato J., Maruyama K., and Mimura G. Effect of chemical and physical treatment on the inactivation of striped jack nervous necrosis virus. Aquaculture 143 (1996) 15-22
7. Beck N.B., Koenig J.Q., Luchtel D.L., Altman L.C., Orsborn M.T., and Kenney J.S. Ozone can increase the expression of intercellular adhesion molecule-1 and the synthesis of cytokines by human nasal epithelial cells. Inhal. Toxicol. 6 (1994) 345-357
8. Becker S., Soupup J.M., Reed W., Carson J., and Devlin R.B. Effect of ozone on susceptibility to respiratory viral infection and virus-induced cytokine secretion. Environ. Toxicol. Pharmacol. 6 (1998) 257-265
9. Berlett B.S., Levine R.L., and Stadtman E.R. Comparison of the effects of ozone on the modification of amino acid residues in glutamine synthetase and bovine serum albumin. J. Biol. Chem. 271 (1996) 4177-4182
10. Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J. Biol. Regul. Homeost. Agents 10 (1996) 31-53
11. Bocci V. Is ozone therapy therapeutic?. Perspect. Biol. Med. 42 (1998) 131-143
12. Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine?. Br. J. Biomed. Sci. 56 (1999) 270-279
13. Bocci V. Scientific and medical aspects of ozone therapy. State of the art. Arch. Med. Res. 37 (2006) 425-435
14. Carpendale M.T., and Freeberg J.K. Ozone inactivates HIV at noncytotoxic concentrations. Antiviral Res. 16 (1991) 281-292
15. Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., Jegathesan M., Anderson L.J., and For the Outbreak Study Group. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin. Infect. Dis. 31 (2000) 678-683
16. Chang L.Y., Lin T.Y., Huang Y.C., Tsao K.C., Shih S.R., Kuo M.L., Ning H.C., Chung P.W., and Kang C.M. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr. Infect. Dis. J. 18 (1999) 1092-1096
17. Czarniecki C.W. The role of tumor necrosis factor in viral disease. Antiviral Res. 22 (1993) 223-258
18. Dodd D.A., Giddings Jr. T.H., and Kirkegaard K. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J. Virol. 75 (2001) 8158-8165
19. Fakhrzadeh L., Laskin J.D., and Laskin D.L. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am. J. Respir. Crit. Care Med. 26 (2002) 413-419
20. Friedman L.I., and Stromberg R.R. Viral inactivation and reduction in cellular blood products. Rev. Fr. Transfus. Hemobiol. 36 (1993) 83-91
21. Fu L., Kaneko T., Ikeda H., Nishiyama H., Suzuki S., Okubo T., Trevisani M., Geppetti P., and Ishigatsubo Y. Tachykinins via tachykinin NK(2) receptor activation mediate ozone-induced increase in the permeability of the tracheal mucosa in guinea-pigs. Br. J. Pharmacol. 135 (2002) 1331-1335
22. Górnicki A., and Gutsze A. In vitro effects of ozone on human erythrocyte membranes: an EPR study. Acta Biochim. Pol. 47 (2000) 963-971
23. Hamelin C., and Chung Y.S. Optimal conditions for mutagenesis by ozone in Escherichia coli K12. Mutat. Res. 24 (1974) 271-279
24. Herbein G., Montaner L.J., and Gordon S. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. J. Virol. 70 (1996) 7388-7397
25. Herbein G., and O'Brien W.A. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 223 (2000) 241-257
26. Herbold K., Flehmig B., and Botzenhart K. Comparison of ozone inactivation, in flowing water, of hepatitis A virus, poliovirus 1, and indicator organisms. Appl. Environ. Microbiol. 55 (1989) 2949-2953
27. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R., and Taiwan Enterovirus Epidemic Working Group. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341 (1999) 929-935
28. Inoue H., Aizawa H., Nakano H., Matsumoto K., Kuwano K., Nadel J.A., and Hara N. Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am. J. Respir. Crit. Care Med. 161 (2000) 249-256
29. Ishimaru Y., Nakano S., Yamaoka K., and Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch. Dis. Child. 55 (1980) 583-588
30. Jakab G.J., and Hmieleski R.R. Reduction of influenza virus pathogenesis by exposure to 0.5 ppm ozone. J. Toxicol. Environ. Health 23 (1988) 455-472
31. Jakab G.J., Spannhake E.W., Canning B.J., Kleeberger S.R., and Gilmour M.I. The effects of ozone on immune function. Environ. Health Perspect. 103 Suppl. 2 (1995) 77-89
32. Jaspers I., Flescher E., and Chen L.C. Respiratory epithelial cells display polarity in their release of the chemokine IL-8 after exposure to ozone. Inflamm. Res. 46 Suppl. 2 (1997) S173-S174
33. Johnston R.A., Schwartzman I.N., Flynt L., and Shore S.A. Role of interleukin-6 in murine airway responses to ozone. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L390-L397
34. Jones K.D., Aoki Y., Chang Y., Moore P.S., Yarchoan R., and Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpes virus-associated infected primary effusion lymphoma cells. Blood 94 (1999) 2871-2879
35. Jörres R.A., Holz O., Zachgo W., Timm P., Koschyk S., Müller B., Grimminger F., Seeger W., Kelly F.J., Dunster C., Frischer T., Lubec G., Waschewski M., Niendorf A., and Magnussen H. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am. J. Respir. Crit. Care Med. 161 (2000) 1855-1861
36. Kafoury R.M., Pryor W.A., Squadrito G.L., Salgo M.G., Zou X., and Friedman M. Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. Am. J. Respir. Crit. Care Med. 160 (1999) 1934-1942
37. Khaiboullina S.F., Netski D.M., Krumpe P., and St Jeor S.C. Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J. Virol. 74 (2000) 11966-11971
38. Kim J.G., Yousef A.E., and Khadre M.A. Ozone and its current and future application in the food industry. Adv. Food Nutr. Res. 45 (2003) 167-218
39. Koike E., Kobayashi T., and Shimojo N. Ozone exposure enhances expression of cell-surface molecules associated with antigen-presenting activity on bronchoalveolar lavage cells in rats. Toxicol. Sci. 63 (2001) 115-124
40. Larini A., and Bocci V. Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol. In Vitro 19 (2005) 55-61
41. Leikauf G.D., Simpson L.G., Santrock J., Zhao Q., Abbinante-Nissen J., Zhou S., and Driscoll K.E. Airway epithelial cell responses to ozone injury. Environ. Health Perspect. 103 Suppl. 2 (1995) 91-95
42. Li M.L., Hsu T.A., Chen T.C., Chang S.C., Lee J.C., Chen C.C., Stollar V., and Shih S.R. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293 (2002) 386-395
43. Liang C.C., Sun M.J., Lei H.Y., Chen S.H., Yu C.K., Liu C.C., Wang J.R., and Yeh T.M. Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J. Med. Virol. 74 (2004) 597-603
44. Lin Y.L., Huang Y.L., Ma S.H., Yeh C.T., Chiou S.Y., Chen L.K., and Liao C.L. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 71 (1997) 5227-5235
45. Lin T.Y., Chang L.Y., Hsia S.H., Huang Y.C., Chiu C.H., Hsueh C., Shih S.R., Liu C.C., and Wu M.H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 34 Suppl. 2 (2002) S52-S57
46. Lin T.Y., Chang L.Y., Huang Y.C., Hsu K.H., Chiu C.H., and Yang K.D. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 91 (2002) 632-635
47. Lin T.Y., Hsia S.H., Huang Y.C., Wu C.T., and Chang L.Y. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 36 (2003) 269-274
48. Lin Y.C., and Wu S.C. Effects of ozone exposure on inactivation of intra- and extracellular enterovirus 71. Antiviral Res. 70 (2006) 147-153
49. Liu C.C., Tseng H.W., Wang S.M., Wang J.R., and Su I.J. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J. Clin. Virol. 17 (2000) 23-30
50. Mannick J.B. The antiviral role of nitric oxide. Res. Immunol. 146 (1995) 693-697
51. Melnick J.L. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev. Infect. Dis. 6 (1984) 5387-5390
52. Miller M.D., and Krangel M.S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12 (1992) 17-46
53. Nathan C. Natural resistance and nitric oxide. Cell 82 (1995) 873-876
54. Neznanov N., Kondratova A., Chumakov K.M., Angres B., Zhumabayeva B., Agol V.I., and Gudkov A.V. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J. Virol. 75 (2001) 10409-10420
55. Nichols B.G., Woods J.S., Luchtel D.L., Corral J., and Koenig J.Q. Effects of ozone exposure on nuclear factor-kappaB activation and tumor necrosis factor-alpha expression in human nasal epithelial cells. Toxicol. Sci. 60 (2001) 356-362
56. In: Oppenheim J.J., and Feldmann M. (Eds). Cytokine Reference vol. 1 (2001), Academic Press, San Diego, CA
57. Park J.W., Taube C., Swasey C., Kodama T., Joetham A., Balhorn A., Takeda K., Miyahara N., Allen C.B., Dakhama A., Kim S.H., Dinarello C.A., and Gelfand E.W. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am. J. Respir. Cell Mol. Biol. 30 (2004) 830-836
58. Pearson A.C., and Bhalla D.K. Effects of ozone on macrophage adhesion in vitro and epithelial and inflammatory responses in vivo: the role of cytokines. J. Toxicol. Environ. Health 50 (1997) 143-157
59. Pendino K.J., Meidhof T.M., Heck D.E., Laskin J.D., and Laskin D.L. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. Am. J. Respir. Cell Mol. Biol. 13 (1995) 125-132
60. Pryor W.A., Squadrito G.L., and Friedman M. A new mechanism for the toxicity of ozone. Toxicol. Lett. 82/83 (1995) 287-293
61. Ramshaw I.A., Ramsay A.J., Karupiah G., Rolph M.S., Mahalingam S., and Ruby J.C. Cytokines and immunity to viral infections. Immunol. Rev. 159 (1997) 119-135
62. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938) s493-s497
63. Roy D., Wong P.K.Y., Engelbrecht R.S., and Chian E.S.K. Mechanism of enteroviral inactivation by ozone. Appl. Environ. Microbiol. 41 (1981) 718-723
64. Rusznak C., Devalia J.L., Sapsford R.J., and Davies R.J. Ozone-induced mediator release from human bronchial epithelial cells in vitro and the influence of nedocromil sodium. Eur. Respir. J. 9 (1996) 2298-2305
65. Selgrade M.J.K., Illing J.W., Starnes D.M., Stead A.G., Ménache M.G., and Stevens M.A. Evaluation of effects of ozone exposure on influenza infection in mice using several indicators of susceptibility. Fundam. Appl. Toxicol. 11 (1988) 169-180
66. Seo S.H., and Webster R.G. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J. Virol. 76 (2002) 1071-1076
67. Shin G.A., and Sobsey M.D. Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by ozone disinfection of water. Appl. Environ. Microbiol. 69 (2003) 3975-3978
68. Shinriki N., Ishizaki K., Ikehata A., Yoshizaki T., Nomura A., Miura K., and Mizuno Y. Degradation of nucleic acids with ozone. II. Degradation of yeast RNA, yeast phenylalanine tRNA and tobacco mosaic virus RNA. Biochim. Biophys. Acta 655 (1981) 323-328
69. Tilg H., Dinarello C.A., and Mier J.W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 18 (1997) 428-432
70. Uppu R.M., Cueto R., Squadrito G.L., and Pryor W.A. What does ozone react with at the air/lung interface? Model studies using human red blood cell membranes. Arch. Biochem. Biophys. 319 (1995) 257-266
71. Wang S.M., Liu C.C., Tseng H.W., Wang J.R., Huang C.C., Chen Y.J., Yang Y.J., Lin S.J., and Yeh T.F. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29 (1999) 184-190
72. Wells K.H., Latino J., Gavalchin J., and Poiesz B.J. Inactivation of human immunodeficiency virus type 1 by ozone in vitro. Blood 78 (1991) 1882-1890
73. Wolcott J.A., Zee Y.C., and Osebold J.W. Exposure to ozone reduces influenza disease severity and alters distribution of influenza viral antigens in murine lungs. Appl. Environ. Microbiol. 44 (1982) 723-731
74. Wróbel A., Jezierski A., and Gomulkiewicz J. Electron paramagnetic resonance studies of proteins in ozone-treated erythrocyte membranes. Biochem. Mol. Biol. Int. 41 (1997) 349-357
75. Wu J.M., Wang J.N., Tsai Y.C., Liu C.C., Huang C.C., Chen Y.J., and Yeh T.F. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics 109 (2002) E26
76. Yan J.J., Wang J.R., Liu C.C., Yang H.B., and Su I.J. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J. Clin. Virol. 17 (2000) 13-22
77. Zaragoza C., Ocampo C.J., Saura M., McMillan A., and Lowenstein C.J. Nitric oxide inhibition of coxsackievirus replication in vitro. J. Clin. Invest. 100 (1997) 1760-1767